KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLoans and Notes ReceivablesLong-Term Debt IssuancesNon-Current ReceivablesReceivables RefundsShares OutstandingShares Repurchased
Ratios

Royalty Pharma (RPRX) Shares Outstanding: 2020-2025

Historic Shares Outstanding for Royalty Pharma (RPRX) over the last 6 years, with Sep 2025 value amounting to $429.0 million.

  • Royalty Pharma's Shares Outstanding fell 3.81% to $429.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $429.0 million, marking a year-over-year decrease of 3.81%. This contributed to the annual value of $446.0 million for FY2024, which is 0.16% down from last year.
  • Latest data reveals that Royalty Pharma reported Shares Outstanding of $429.0 million as of Q3 2025, which was down 0.75% from $432.3 million recorded in Q2 2025.
  • In the past 5 years, Royalty Pharma's Shares Outstanding registered a high of $451.0 million during Q1 2024, and its lowest value of $392.9 million during Q1 2021.
  • For the 3-year period, Royalty Pharma's Shares Outstanding averaged around $442.7 million, with its median value being $446.0 million (2024).
  • Per our database at Business Quant, Royalty Pharma's Shares Outstanding increased by 16.70% in 2021 and then fell by 5.63% in 2025.
  • Over the past 5 years, Royalty Pharma's Shares Outstanding (Quarterly) stood at $433.0 million in 2021, then grew by 2.36% to $443.2 million in 2022, then increased by 0.80% to $446.7 million in 2023, then declined by 0.16% to $446.0 million in 2024, then declined by 3.81% to $429.0 million in 2025.
  • Its Shares Outstanding stands at $429.0 million for Q3 2025, versus $432.3 million for Q2 2025 and $425.6 million for Q1 2025.